US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
SO

SOL.MI

$55.60
Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.13%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

SOL S.p.A. (SOL.MI) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$61.62
+10.8% · 4 analysts
Institutional own.
20.9%
of shares
COMPLIANT
Sharia compliance
0.13%
Non-permissible income — HTR, from filings (2025-06-30)
$61.62
Price target (+10.8%) · 4 analysts
20.9%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-06-30. SOL.MI files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 15.01% 30.00% Pass
Interest-bearing investments 5.33% 30.00% Pass
Non-permissible income 0.13% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 32.11% 33.00% Pass
Interest-bearing investments 11.40% 33.00% Pass
Non-liquid assets 64.87% at least 20.00% Pass
Non-permissible income 0.13% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 32.11% 33.33% Pass
Cash + interest-bearing securities 11.40% 33.33% Pass
Accounts receivable 35.13% 33.33% Fail
Non-permissible income 0.13% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 32.11% 33.33% Pass
Cash + interest-bearing securities 11.40% 33.33% Pass
Accounts receivable 35.13% 50.00% Pass
Non-permissible income 0.13% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 17.88% 33.00% Pass
Cash + interest-bearing securities 6.34% 33.00% Pass
Accounts receivable 13.21% 33.00% Pass
Non-permissible income 0.13% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 20.33% 33.00% Pass
Cash + interest-bearing securities 7.21% 49.00% Pass
Accounts receivable 15.02% 49.00% Pass
Non-permissible income 0.13% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 20.33% 33.33% Pass
Cash + interest-bearing securities 7.21% 33.33% Pass
Accounts receivable 22.24% 49.00% Pass
Non-permissible income 0.13% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

63.4058.8154.2349.6445.052025-09-112026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
47.80
S2
51.00
S1
52.60
PIVOT
55.80
R1
57.40
R2
60.60
R3
62.20

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
52.2495 58.7505
±5.86% from 55.5, made 2026-09-02 · resolves 2026-09-09
BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21972 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

SELL
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG SELL
4 buy · 0 neutral · 8 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)49.00NEUTRAL
Stochastic %K (14)50.72NEUTRAL
CCI (20)56.14NEUTRAL
Williams %R (14)-49.28NEUTRAL
MACD (12,26,9)0.33BUY
ROC (10)3.92BUY
Momentum (10)2.10BUY
EMA (10)55.83SELL
SMA (10)56.17SELL
EMA (20)55.66SELL
SMA (20)54.71BUY
EMA (30)55.92SELL
SMA (30)55.04BUY
EMA (50)56.46SELL
SMA (50)57.33SELL
EMA (100)56.47SELL
SMA (100)57.81SELL
EMA (200)54.15BUY
SMA (200)54.03BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About SOL S.p.A.

Basic Materials · Specialty Chemicals

SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.

solgroup.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio no data
Investments ratio 4.6% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio no data
Investments ratio 10.8% (< 33%)
Nonliquid assets ratio 89.2% (< 20%)
Non permissible income ratio no data
Net liquid assets no data

Based on the filing period ending 2024-12-31, figures in EUR.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.